J-Pharma Co (TSE:520A) Buyback Yield %: 0.00 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:520A J-Pharma Co Ltd TSE:520A
9 GF Score
Price 円290.00
View Full Analysis

What is J-Pharma Co Buyback Yield %?

J-Pharma Co TSE:520A -2.36% 9 Buyback Yield % is 0.00 as of Jul. 14, 2026. GuruFocus rates TSE:520A with a GF Score™ of 9/100. Among 742 Biotechnology companies, J-Pharma Co ranks worse than 134770.75% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

J-Pharma Co's current buyback yield was 0.00%.

J-Pharma Co Buyback Yield % Historical Data

* Premium members only.

The historical data trend for J-Pharma Co's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

J-Pharma Co Buyback Yield % Chart

J-Pharma Co Annual Data
Trend Mar24 Mar25
Buyback Yield %
0.00 0.00

J-Pharma Co Quarterly Data
Mar24 Mar25 Dec25
Buyback Yield % 0.00 0.00 0.00

TSE:520A vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, J-Pharma Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

J-Pharma Co Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, J-Pharma Co's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where J-Pharma Co's Buyback Yield % falls into.


TSE:520A
9GF Score
J-Pharma Co Ltd TSE:520A
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

J-Pharma Co Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

J-Pharma Co's Buyback Yield for the fiscal year that ended in Mar. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 2924) / 0
=N/A%

J-Pharma Co's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
J-Pharma Co (TSE:520A) has a Buyback Yield % of 0.00 as of Jul. 14, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on J-Pharma Co and its competitors. According to the industry distribution chart, J-Pharma Co ranks #999999 out of 742 companies in the Biotechnology industry.
Is J-Pharma Co's Buyback Yield % too high?
J-Pharma Co's current Buyback Yield % is 0.00. Based on the distribution chart, J-Pharma Co ranks #999999 out of 742 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, J-Pharma Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does J-Pharma Co's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, J-Pharma Co ranks #999999 out of 742 companies for Buyback Yield %. This places J-Pharma Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on J-Pharma Co and its competitors. J-Pharma Co's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J-Pharma Co stock overvalued right now?
J-Pharma Co (TSE:520A) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. J-Pharma Co's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For J-Pharma Co (TSE:520A), the current Buyback Yield % is 0.00 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

J-Pharma Co Business Description

Address 1-10-11, HamamatsuCho, 8th floor, Minato-Ku, Tokyo, JPN, 105-0013
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.
9GF Score

Get the complete analysis for TSE:520A

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円290.00
Price